195 related articles for article (PubMed ID: 17656390)
21. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century.
Paskovaty A; Pflomm JM; Myke N; Seo SK
Int J Antimicrob Agents; 2005 Jan; 25(1):1-10. PubMed ID: 15620820
[TBL] [Abstract][Full Text] [Related]
22. When medicines fail: recommendations for curbing antibiotic resistance.
Nugent R; Okeke IN
J Infect Dev Ctries; 2010 Jun; 4(6):355-6. PubMed ID: 20601785
[No Abstract] [Full Text] [Related]
23. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
Spellberg B; Guidos R; Gilbert D; Bradley J; Boucher HW; Scheld WM; Bartlett JG; Edwards J;
Clin Infect Dis; 2008 Jan; 46(2):155-64. PubMed ID: 18171244
[TBL] [Abstract][Full Text] [Related]
24. Report of the ASM task force on antibiotic resistance.
Antimicrob Agents Chemother; 1995; Suppl():1-23. PubMed ID: 7654082
[No Abstract] [Full Text] [Related]
25. Lack of development of new antimicrobial drugs: a potential serious threat to public health.
Norrby SR; Nord CE; Finch R;
Lancet Infect Dis; 2005 Feb; 5(2):115-9. PubMed ID: 15680781
[TBL] [Abstract][Full Text] [Related]
26. Regulatory opportunities to encourage technology solutions to antibacterial drug resistance.
Finch R;
J Antimicrob Chemother; 2011 Sep; 66(9):1945-7. PubMed ID: 21700629
[TBL] [Abstract][Full Text] [Related]
27. [New guidelines for antibiotic use in primary health care].
Eliassen KE; Fetveit A; Hjortdahl P; Berild D; Lindbaek M
Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2330-4. PubMed ID: 19096489
[TBL] [Abstract][Full Text] [Related]
28. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial stewardship: concepts and strategies in the 21st century.
Owens RC
Diagn Microbiol Infect Dis; 2008 May; 61(1):110-28. PubMed ID: 18384997
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance: a view from the prescriber.
Finch RG
Nat Rev Microbiol; 2004 Dec; 2(12):989-94. PubMed ID: 15550945
[TBL] [Abstract][Full Text] [Related]
31. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
Gyssens IC
Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
[TBL] [Abstract][Full Text] [Related]
32. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic resistance: the perfect storm.
Gould IM
Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S2-5. PubMed ID: 19596110
[TBL] [Abstract][Full Text] [Related]
34. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
35. Predicting antibiotic resistance.
MartÃnez JL; Baquero F; Andersson DI
Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
[TBL] [Abstract][Full Text] [Related]
36. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
Infectious Diseases Society of America
Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
[TBL] [Abstract][Full Text] [Related]
37. The new treatment paradigm and the role of carbapenems.
Masterton RG
Int J Antimicrob Agents; 2009 Feb; 33(2):105-110. PubMed ID: 18848436
[TBL] [Abstract][Full Text] [Related]
38. European Antibiotic Awareness Day 2012: getting smart about antibiotics, a public-professional partnership.
Stockley JM
J Infect; 2012 Nov; 65(5):377-9. PubMed ID: 22960369
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic stewardship: overcoming implementation barriers.
Bal AM; Gould IM
Curr Opin Infect Dis; 2011 Aug; 24(4):357-62. PubMed ID: 21587070
[TBL] [Abstract][Full Text] [Related]
40. Late stage antibacterial drugs in the clinical pipeline.
Projan SJ; Bradford PA
Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
